Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8754)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2013 (publication date) through Apr 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen Y, Sun XJ, Jiang TH, Mao AW. Combined radiochemotherapy in patients with locally advanced pancreatic cancer: A meta-analysis. World J Gastroenterol 2013; 19(42): 7461-7471 [PMID: 24259979 DOI: 10.3748/wjg.v19.i42.7461] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i42/7461.htm |
| Number | Citing Articles |
| 1 |
M. Tonneau, T. Lacornerie, X. Mirabel, D. Pasquier. Radiothérapie stéréotaxique dans le cancer du pancréas localement avancé : revue de la littérature. Cancer/Radiothérapie 2021; 25(3): 283 doi: 10.1016/j.canrad.2020.08.047
|
| 2 |
Jee Suk Chang, Seo Hee Choi, Youngin Lee, Kyung Hwan Kim, Jeong Youp Park, Si Young Song, Arthur Cho, Mijin Yun, Jong Doo Lee, Jinsil Seong. Clinical Usefulness of 18F-Fluorodeoxyglucose-Positron Emission Tomography in Patients With Locally Advanced Pancreatic Cancer Planned to Undergo Concurrent Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics 2014; 90(1): 126 doi: 10.1016/j.ijrobp.2014.05.030
|
| 3 |
A. Allam Mohamed, Andreas Thomsen, Marie Follo, Costantinos Zamboglou, Peter Bronsert, Hanan Mostafa, Aber Amen, Mohamed Mekawy, Anca L. Grosu, Thomas B. Brunner. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro. Strahlentherapie und Onkologie 2021; 197(1): 27 doi: 10.1007/s00066-020-01666-0
|
| 4 |
Jin Sheng, Yun-Peng Yang, Bi-Jun Yang, Yuan-Yuan Zhao, Yu-Xiang Ma, Shao-Dong Hong, Ya-Xiong Zhang, Hong-Yun Zhao, Yan Huang, Li Zhang. Efficacy of Addition of Antiangiogenic Agents to Taxanes-Containing Chemotherapy in Advanced Nonsmall-Cell Lung Cancer. Medicine 2015; 94(31): e1282 doi: 10.1097/MD.0000000000001282
|
| 5 |
Osama Al-Assar, Martin-Immanuel Bittner, Serena Lunardi, Michael R. Stratford, W. Gillies McKenna, Thomas B. Brunner. The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells. Radiotherapy and Oncology 2016; 119(2): 300 doi: 10.1016/j.radonc.2016.03.024
|
| 6 |
Quan-Jun Lin, Feng Yang, Chen Jin, De-Liang Fu. Current status and progress of pancreatic cancer in China. World Journal of Gastroenterology 2015; 21(26): 7988-8003 doi: 10.3748/wjg.v21.i26.7988
|
| 7 |
Moritz Reese, Sameer A. Dhayat. Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications. Journal of Hematology & Oncology 2021; 14(1) doi: 10.1186/s13045-021-01149-4
|
| 8 |
Thangirala Sudha, Kavitha Godugu, Gennadi V. Glinsky, Shaker A. Mousa. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin αvβ3 Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. Biomedicines 2022; 10(4): 795 doi: 10.3390/biomedicines10040795
|
| 9 |
Diego Tristán Enjuto, Norberto Herrera Merino, José María Abadal Villandrade, Esther Gálvez González, Rosa Llorente Lázaro, Patricia Díaz Peña, María Jesús Álvarez Pérez, Marta Pérez González. Irreversible Electroporation in Locally Advanced Pancreatic Adenocarcinoma: Aiming to Improve Overall Survival. Journal of Gastrointestinal Cancer 2020; 51(3): 1084 doi: 10.1007/s12029-020-00425-9
|
| 10 |
Yi-Jun Kim, Hyeon Kang Koh, Eui Kyu Chie, Do-Youn Oh, Yung-Jue Bang, Eun Mi Nam, Kyubo Kim. Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy . International Journal of Clinical Oncology 2017; 22(6): 1069 doi: 10.1007/s10147-017-1129-7
|
| 11 |
Marc A. Attiyeh, Arya Amini, Vincent Chung, Laleh G. Melstrom. Multidisciplinary management of locally advanced pancreatic adenocarcinoma: Biology is King. Journal of Surgical Oncology 2021; 123(6): 1395 doi: 10.1002/jso.26415
|
| 12 |
Siobhra O’Sullivan, Daniel N. Cagney. The emerging role of stereotactic radiotherapy in gastrointestinal malignancies: a review of the literature and analysis from the Irish perspective. Irish Journal of Medical Science (1971 -) 2018; 187(4): 887 doi: 10.1007/s11845-018-1755-8
|
| 13 |
Venessa Chin, Adnan Nagrial, Katrin Sjoquist, Chelsie A O'Connor, Lorraine Chantrill, Andrew V Biankin, Rob JPM Scholten, Desmond Yip. Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database of Systematic Reviews 2018; 2018(3) doi: 10.1002/14651858.CD011044.pub2
|
| 14 |
Zuguang Xia, Xiaoyan Jia, Kai Chen, Dapeng Li, Jing Xie, Hong Xu, Yixiang Mao. Survival benefits from postoperative radiation therapy on lymph node positive patients with pancreatic adenocarcinoma. Oncotarget 2016; 7(29): 46646 doi: 10.18632/oncotarget.9620
|
| 15 |
Masahiko Okamoto, Shintaro Shiba, Shohei Okazaki, Yuhei Miyasaka, Kei Shibuya, Hiroki Kiyohara, Tatsuya Ohno. Feasibility and Safety of Repeated Carbon Ion Radiotherapy for Locally Advanced Unresectable Pancreatic Cancer. Cancers 2021; 13(4): 665 doi: 10.3390/cancers13040665
|
| 16 |
Masahiko Okamoto, Shintaro Shiba, Daijiro Kobayashi, Yuhei Miyasaka, Shohei Okazaki, Kei Shibuya, Tatsuya Ohno. Carbon-Ion Radiotherapy Combined with Concurrent Chemotherapy for Locally Advanced Pancreatic Cancer: A Retrospective Case Series Analysis. Cancers 2023; 15(10): 2857 doi: 10.3390/cancers15102857
|
| 17 |
Niloy Ranjan Datta, Bernhard Pestalozzi, Pierre-Alain Clavien, Alexander Siebenhüner, Emsad Puric, Shaka Khan, Christoph Mamot, Oliver Riesterer, Jürg Knuchel, Cäcilia Sophie Reiner, Stephan Bodis. “HEATPAC” - a phase II randomized study of concurrent thermochemoradiotherapy versus chemoradiotherapy alone in locally advanced pancreatic cancer. Radiation Oncology 2017; 12(1) doi: 10.1186/s13014-017-0923-8
|
| 18 |
S.J. Rogers, N.R. Datta, E. Puric, O. Timm, D. Marder, S. Khan, C. Mamot, J. Knuchel, A. Siebenhüner, B. Pestalozzi, M. Guckenberger, S. Bodis, O. Riesterer. The addition of deep hyperthermia to gemcitabine-based chemoradiation may achieve enhanced survival in unresectable locally advanced adenocarcinoma of the pancreas. Clinical and Translational Radiation Oncology 2021; 27: 109 doi: 10.1016/j.ctro.2021.01.008
|
| 19 |
Kazuho Inoko, Kei Hiraoka, Akihito Inagaki, Mizuna Takahashi, Toshihiro Kushibiki, Koji Hontani, Hironobu Takano, Shoki Sato, Shintaro Takeuchi, Toru Nakamura, Takahiro Tsuchikawa, Toshiaki Shichinohe, Harry E Gruber, Douglas J Jolly, Noriyuki Kasahara, Satoshi Hirano. Therapeutic activity of retroviral replicating vector-mediated prodrug activator gene therapy for pancreatic cancer. Cancer Gene Therapy 2018; 25(7-8): 184 doi: 10.1038/s41417-018-0020-7
|
| 20 |
LEI LI, BAIWEN LI, DAFAN CHEN, LIYAN LIU, CHEN HUANG, ZHANJUN LU, LUNGEN LUN, XINJIAN WAN. miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis. Oncology Reports 2015; 34(1): 51 doi: 10.3892/or.2015.3945
|
| 21 |
Thangirala Sudha, Mahboob Ur Rehman, Noureldien H. E. Darwish, Melis Debreli Coskun, Jahangir A. Satti, Paul J. Davis, Shaker A. Mousa. Nano-Targeting of Thyrointegrin αvβ3 Receptor in Solid Tumors and Impact on Radiosensitization. Radiation Research 2021; 196(4) doi: 10.1667/RADE-21-00031.1
|
| 22 |
H. Liang, S. Williamson. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_31-1
|
| 23 |
M. Salgado, S. Arévalo, O. Hernando, A. Martínez, R. Yaya, M. Hidalgo. Management of unresectable, locally advanced pancreatic adenocarcinoma. Clinical and Translational Oncology 2018; 20(2): 113 doi: 10.1007/s12094-017-1679-1
|
| 24 |
Shih‐Hung Yang, Jhe‐Cyuan Guo, Kun‐Huei Yeh, Yu‐Wen Tien, Ann‐Lii Cheng, Sung‐Hsin Kuo. Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer. Journal of Gastroenterology and Hepatology 2016; 31(12): 2004 doi: 10.1111/jgh.13395
|
| 25 |
H. Liang, S. Williamson. Hepato-Pancreato-Biliary Malignancies. 2022; : 535 doi: 10.1007/978-3-030-41683-6_31
|
| 26 |
Nicole L. Goerig, Rainer Fietkau. Rolle der Radiotherapie beim Pankreaskarzinom. Wiener klinisches Magazin 2020; 23(1): 14 doi: 10.1007/s00740-020-00326-4
|
| 27 |
JUN GONG, RICHARD TULI, ARVIND SHINDE, ANDREW E. HENDIFAR. Meta-analyses of treatment standards for pancreatic cancer. Molecular and Clinical Oncology 2016; 4(3): 315 doi: 10.3892/mco.2015.716
|
| 28 |
Annette A. van Zweeden, Hans J. van der Vliet, Johanna W. Wilmink, Martijn R. Meijerink, Otto W.M. Meijer, Anna M.E. Bruynzeel, Geertjan van Tienhoven, Elisa Giovannetti, Geert Kazemier, Maarten A.J.M. Jacobs, Henk M.W. Verheul. Phase I Clinical Trial to Determine the Feasibility and Maximum Tolerated Dose of Panitumumab to Standard Gemcitabine-Based Chemoradiation in Locally Advanced Pancreatic Cancer. Clinical Cancer Research 2015; 21(20): 4569 doi: 10.1158/1078-0432.CCR-14-3364
|
| 29 |
Ilhan Karabicak, Sohei Satoi, Hiroaki Yanagimoto, Tomohisa Yamamoto, Satoshi Hirooka, So Yamaki, Hisashi Kosaka, Kentaro Inoue, Yoichi Matsui, Masanori Kon. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2016; 23(12): 750 doi: 10.1002/jhbp.408
|
| 30 |
Barbara Salas-Salas, Laura Ferrera-Alayon, Alberto Espinosa-Lopez, Maria Luisa Perez-Rodriguez, Antonio Alayón Afonso, Andres Vera-Rosas, Gabriel Garcia-Plaza, Rodolfo Chicas-Sett, Maria Soledad Martinez-Martin, Elisa Salcedo, Andrea Kannemann, Marta Lloret-Saez-Bravo, Pedro C. Lara. Dose-Escalated SBRT for Borderline and Locally Advanced Pancreatic Cancer: Resectability Rate and Pathological Results of a Multicenter Prospective Study. Cancers 2025; 17(2): 191 doi: 10.3390/cancers17020191
|
| 31 |
B. Salas, L. Ferrera-Alayón, A. Espinosa-López, A. Vera-Rosas, E. Salcedo, A. Kannemann, A. Alayon, R. Chicas-Sett, M. LLoret, P.C. Lara. Dose-escalated SBRT for borderline and locally advanced pancreatic cancer. Feasibility, safety and preliminary clinical results of a multicenter study. Clinical and Translational Radiation Oncology 2024; 45: 100753 doi: 10.1016/j.ctro.2024.100753
|
| 32 |
Agnieszka Smolinska, Julia Swoboda, Wojciech Fendler, Markus M. Lerch, Matthias Sendler, Patryk Moskwa. MiR-502 is the first reported miRNA simultaneously targeting two components of the classical non-homologous end joining (C-NHEJ) in pancreatic cell lines. Heliyon 2020; 6(1): e03187 doi: 10.1016/j.heliyon.2020.e03187
|
| 33 |
Takeshi Saito, Keinosuke Ishido, Daisuke Kudo, Norihisa Kimura, Taiichi Wakiya, Yoshihito Nakayama, Kenichi Hakamada. Combination therapy with gemcitabine and nab-paclitaxel for locally advanced unresectable pancreatic cancer. Molecular and Clinical Oncology 2017; 6(6): 963 doi: 10.3892/mco.2017.1251
|
| 34 |
Christopher M. Halloran, Frances E. Oldfield, John P. Neoptolemos. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1032 doi: 10.1016/B978-0-323-34062-5.00068-6
|
| 35 |
Alberto Servetto, Antonio Santaniello, Fabiana Napolitano, Francesca Foschini, Roberta Marciano, Eleonora Mozzillo, Priscilla Cascetta, Anna Rita Amato, Maria Rosaria Augurio, Lucia Maresca, Pietro De Placido, Sabino De Placido, Luigi Formisano, Roberto Bianco. Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers 2021; 13(19): 4939 doi: 10.3390/cancers13194939
|
| 36 |
Ko Tomishima, Shigeto Ishii, Toshio Fujisawa, Muneo Ikemura, Hiroto Ota, Daishi Kabemura, Mako Ushio, Taito Fukuma, Sho Takahashi, Wataru Yamagata, Yusuke Takasaki, Akinori Suzuki, Koichi Ito, Hiroaki Saito, Akihito Nagahara, Hiroyuki Isayama. Duration of Reduced CA19-9 Levels Is a Better Prognostic Factor Than Its Rate of Reduction for Unresectable Locally Advanced Pancreatic Cancer. Cancers 2021; 13(16): 4224 doi: 10.3390/cancers13164224
|
| 37 |
Nicole L. Goerig, Rainer Fietkau. Rolle der Radiotherapie beim Pankreaskarzinom. Der Onkologe 2019; 25(8): 678 doi: 10.1007/s00761-019-0546-9
|